Immunohistochemical expression of podocyte markers in the variants of focal segmental glomerulosclerosis

Nephrology Dialysis Transplantation

Volumn 28, Issue 1, 2013, Pages 91-98

  Testagrossa, Leonardo ^a   Azevedo Neto, Raymundo ^a   Resende, Aline ^a   Woronik, Viktoria ^a   Malheiros, Denise ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

collapsing FSGS; focal segmental glomerulosclerosis; FSGS; immunohistochemistry; podocytes; variants of FSGS

Indexed keywords

ALPHA ACTININ 4; CELL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; KI 67 ANTIGEN; PROTEIN GLEPP 1; SYNAPTOPODIN; UNCLASSIFIED DRUG; VIMENTIN; WT1 PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELLULAR VARIANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS; COLLAPSING VARIANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; FOCAL GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; NOT OTHERWISE SPECIFIED VARIANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PERIHILAR VARIANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TIP LESION VARIANT FOCAL SEGMENTAL GLOMERULOSCLEROSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; PODOCYTES; YOUNG ADULT;

EID: 84872229572     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs325     Document Type: Article

References (32)

1. Haas M, Spargo BH, Coventry S. Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis 1995; 26: 740-750.
2. Bahiense-Oliveira M, Saldanha LB, Mota EL et al. Primary glomerular diseases in Brazil (1979-1999): is the frequency of focal and segmental glomerulosclerosis increasing? Clin Nephrol 2004; 61: 90-97.
3. Haas M, Meehan SM, Karrison TG et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997; 30: 621-631.
4. Malafronte P, Mastroianni-Kirsztajn G, Betonico GN et al. Paulista registry of glomerulonephritis: year data report. Nephrol Dial Transplant 2006; 21: 3098-3105.
5. Korbet SM. Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 1998; 9: 1333-1340.
6. Sharma M, Sharma R, McCarthy ET et al. The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects. Exp Biol Med (Maywood) 2004; 229: 85-98.
7. Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol 2007; 2: 529-542.
8. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307.
9. Koop K, Eikmans M, Baelde HJ et al. Expression of podocyteassociated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14: 2063-2071.
10. Bariety J, Bruneval P, Meyrier A et al. Podocyte involvement in human immune crescentic glomerulonephritis. Kidney Int 2005; 68: 1109-1119.
11. D'Agati VD, Fogo AB, Bruijn JA et al. Pathological classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004; 43: 368-382.
12. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994; 46: 1223-1241.
13. Silverstein DM, Craver R. Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2007; 2: 700-707.
14. Valeri A, Barisoni L, Appel G et al. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int 1996; 50: 1734-1746.
15. Thomas DB, Franceschini N, Hogan SL et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 2006; 69: 920-926.
16. Barisoni L, Kriz W, Mundel P et al. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10: 51-61.
17. Shankland SJ, Eitner F, Hudgkins KL et al. Differential expression of cyclindependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 2000; 58: 674-683.
18. Meyrier AY. Collapsing glomerulopathy: expanding interest in a shrinking tuft. Am J Kidney Dis 1999; 33: 801-803.
19. Chun MJ, Korbet SM, Scwartz MM et al. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004; 15: 2169.
20. Stokes MB, Valeri AM, Markowitz GS et al. Cellular focal segmental glomerulosclerosis: clinical and pathological features. Kidney Int 2006; 70: 1783-1792.
21. Haas M. The glomerular tip lesion: what does it really mean? Kidney Int 2005; 67: 1188-1189.
22. Endlich N, Kress KR, Reiser J et al. Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 2001; 12: 413-422.
23. Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24: 251-256.
24. Goode NP, Shires M, Khan TN et al. Expression of α-actinin-4 in acquired human nephrotic syndrome: a quantitative immunoelectron microscopy study. Nephrol Dial Transplant 2004; 19: 844-851.
25. Albaqumi M, Barisoni L. Current views on collapsing glomerulopathy. J Am Soc Nephrol 2008; 19: 1276-1281.
26. Ohtaka A, Ootaka P, Sato H et al. Phenotypic change of glomerular podcytes in primary focal segmental glomerulosclerosis: developmental paradigm? Nephrol Dial Transplant 2002; 17: 11-15.
27. Barisoni L, Schnaper HW, Kopp JB. Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med 2009; 133: 201-216.
28. Quinlan RA, Schiller DL, Hatzfeld M et al. Patterns of expression and organization of cytokeratin intermediate filaments. Ann N Y Acad Sci 1985; 455: 282-306.
29. Miao J, Fan Q, Cui Q et al. Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes. Nephrol Dial Transplant 2009; 24: 3297-3305. Epub 2009 Jul 17.
30. Dijkman H, Smeets B, van der Laak J et al. the parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney Int 2005; 68: 1562-1572.
31. Dijkman HBPM, Weening JJ, Smeets B et al. proliferating cells in HIV and pamidronateassociated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 2006; 70: 338-344.
32. Bariety J, Mandet C, Hill GS et al. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 2006; 17: 2770-2780.